Eton's Galzin TM And False Ad Suit Survives Dismissal Bid
By Ivan Moreno · August 26, 2026, 8:31 PM EDT
Eton Pharmaceuticals can proceed with trademark infringement and false advertising claims accusing Extreme V of marketing a dietary supplement as a Wilson disease treatment, with a Michigan federal judge finding that...
To view the full article, register now.